Abstract
e16528Background: 11C-choline positron emission tomography (11C-PET) is an FDA approved test for the identification of recurrent and metastatic prostate cancer in patients with biochemical recurren...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
